CAR-T therapies

LIVE JUNE 23rd, 2022 at 2:30 PM
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.

Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial

Researchers have published on a new CAR-T cell therapy using CXCR5

Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies